Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Functional 3D Neural Network Models Generated from Stem Cells

By LabMedica International staff writers
Posted on 01 Nov 2018
A team of biomedical engineers worked with human induced pluripotent stem cells (iPSCs) to develop three-dimensional (3D) in vitro human neural network model systems.

Three-dimensional in vitro cell and tissue culture models allow for the exploration of mechanisms of organ development, cellular interactions, and disease progression within defined environments. More...
Investigators at Tufts University (Boston, MA, USA) used iPSCs from normal and diseased individuals to populate a three-dimensional matrix of silk protein and collagen to create such models, which would mimic structural and functional features of the brain and demonstrate neural activity.

The current work was based on previous studies where primary rodent neurons were successfully grown in a similar three-dimensional system. The model was adapted to human induced pluripotent stem cells, allowing for a more direct exploration of the human condition.

The investigators reported in the October 1, 2018, online edition of the journal ACS Biomaterials Science & Engineering that these tissue cultures comprised diverse cell populations, including neurons and astroglial cells, interacting in three-dimensions and exhibited spontaneous neural activity confirmed through electrophysiological recordings and calcium imaging over at least nine months. Compared to growing and culturing cells in two dimensions, the three-dimensional matrix produced a significantly more complete mix of cells found in neural tissue, with the appropriate morphology and expression of receptors and neurotransmitters.

This approach, which was tested with stem cells derived from healthy individuals as well as from Alzheimer’s and Parkinson’s disease patients, allowed for the direct integration of pluripotent stem cells into the three-dimensional construct, bypassing early neural differentiation steps. This streamlined process, in combination with the longevity of the cultures, provided a system that could be manipulated to support a variety of experimental applications such as investigating drug targets in neurodegenerative diseases.

"We found the right conditions to get the iPSCs to differentiate into a number of different neural subtypes, as well as astrocytes that support the growing neural networks," said senior author Dr. David L. Kaplan, professor of biomedical engineering at Tufts University. "The silk-collagen scaffolds provide the right environment to produce cells with the genetic signatures and electrical signaling found in native neuronal tissues."

Related Links:
Tufts University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Platelet Function Analyzer
PL-12
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.